2026 Marcus A. Mall: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	85	3131	2883	239	227	451	27736

Overview

Marcus A. Mall is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily spans the field of Medicine with a strong focus on Pulmonary and Respiratory Medicine, Infectious Diseases, Immunology, Epidemiology, and Molecular Biology.

Their work covers several major research topics, including:

Cystic Fibrosis Research Advances
Neonatal Respiratory Health Research
Tracheal and airway disorders
Pediatric health and respiratory diseases
Respiratory viral infections research
SARS-CoV-2 and COVID-19 Research
COVID-19 Clinical Research Studies

Marcus A. Mall has contributed extensively to numerous scientific papers, with some recent significant publications including:

"SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19" (2020), published in Nature
"Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children" (2021), published in Nature Biotechnology
"Cross-reactive CD4 ⁺ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination" (2021), published in Science
"Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells" (2021), published in Nature
"A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele" (2021), published in American Journal of Respiratory and Critical Care Medicine

Their frequent collaborators include:

Mirjam Stahl
Simon Y. Graeber
Olaf Sommerburg
Mark O. Wielpütz
Julia Duerr

Publications by Marcus A. Mall appear predominantly in the following journals and venues:

Journal of Cystic Fibrosis
bioRxiv (Cold Spring Harbor Laboratory)
European Respiratory Journal
American Journal of Respiratory and Critical Care Medicine
Klinische Pädiatrie

Best Publications

Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

Peter G. Middleton;Marcus A. Mall;Pavel Dřevínek;Larry C. Lands

1681
Citations
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.

Julian Braun;Lucie Loyal;Marco Frentsch;Daniel Wendisch

1248
Citations
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation : a double-blind, randomised, phase 3 trial

Harry G M Heijerman;Edward F McKone;Damian G Downey;Eva Van Braeckel

1153
Citations
Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.

Marcus Mall;Barbara R Grubb;Jack R Harkema;Wanda K O'Neal

1054
Citations
Electrolyte Transport in the Mammalian Colon: Mechanisms and Implications for Disease

Karl Kunzelmann;Marcus Mall

801
Citations
VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.

Dominic Keating;Gautham Marigowda;Lucy Burr;Cori Daines

610
Citations
The future of cystic fibrosis care: a global perspective

Scott C Bell;Marcus A Mall;Hector Gutierrez;Milan Macek

529
Citations
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children.

Jennifer Loske;Jobst Röhmel;Soeren Lukassen;Sebastian Stricker

368
Citations
VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

Jane C. Davies;Samuel M. Moskowitz;Cynthia Brown;Alexander Horsley

334
Citations
Characterization of Wild-Type and ΔF508 Cystic Fibrosis Transmembrane Regulator in Human Respiratory Epithelia

Silvia M. Kreda;Marcus Mall;April Mengos;Lori Rochelle

311
Citations
Cross-reactive CD4 + T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.

Lucie Loyal;Lucie Loyal;Julian Braun;Julian Braun;Larissa Henze;Larissa Henze;Beate Kruse;Beate Kruse

298
Citations
Innate immunity in cystic fibrosis lung disease

D. Hartl;A. Gaggar;E. Bruscia;A. Hector

294
Citations
CFTR: cystic fibrosis and beyond

Marcus A. Mall;Dominik Hartl

287
Citations
Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease.

Mark O. Wielputz;Michael Puderbach;Annette Kopp-Schneider;Mirjam Stahl

286
Citations
Role of Cilia, Mucus, and Airway Surface Liquid in Mucociliary Dysfunction: Lessons from Mouse Models

Marcus A. Mall

285
Citations
CXCR2 mediates NADPH oxidase–independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation

Veronica Marcos;Zhe Zhou;Ali Önder Yildirim;Alexander Bohla

271
Citations
The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.

M Mall;M Bleich;R Greger;R Schreiber

256
Citations
Development of Chronic Bronchitis and Emphysema in β-Epithelial Na+ Channel–Overexpressing Mice

Marcus A. Mall;Jack R. Harkema;Joanna B. Trojanek;Diana Treis

222
Citations
Morphologic and functional scoring of cystic fibrosis lung disease using MRI

Monika Eichinger;Daiva Elzbieta Optazaite;Annette Kopp-Schneider;Christian Hintze

218
Citations
Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis

Mirjam Stahl;Mark O Wielpütz;Simon Y Graeber;Cornelia Joachim

216
Citations